The registry will combine the resources of lung cancer physicians and scientists worldwide by pooling data in one location.  Then, by organizing the data and making it accessible, the registry will dramatically increase the potential to identify people at highest risk of lung cancer and to detect lung cancer at its earliest stage.  By all accounts the registry's return on investment should be remarkable and operational costs for the registry's first five years are extremely modest estimate at only $1,250,000.

Under the direction of Mary Reid. PhD, and Alex Adjei, MD, PhD, representatives from registry partner cancer centers meet regularly to guide, support, and promote use of the registry.